Introduction
Presently Leptospira bacteria are divided according to genetic relatedness based on 16S rRNA: pathogenic (Leptospira Ganoza et al., 2010) . LipL32 is regarded as a major outer membrane lipoprotein, which is highly conserved at both genetic and protein levels (Haake et al., 2000; Guerreiro et al., 2001; Murray, 2013) . This protein was found to be Leptospira hemolysin and enhances the hemolytic activity of sphingomyelinase-H (SphH), and hence given its synonym, hemolysis-associated protein-1 (Hap-1) (Lee et al., 2000; Hauk et al., 2005) . Pathogenicityrelated Leptospira expresses LipL32 constitutively in both the in vitro culture and the infecting mammalian hosts (Haake et al., 2000; Sakolvaree et al., 2007) . The protein is highly immunogenic; LipL32-specific IgG can be detected in acute and convalescing leptospirosis sera (Guerreiro et al., 2001; Sakolvaree et al., 2007) and has been identified as a member of Leptospira adhesive matrices (MSCRAMMs), responsible for binding to the extracellular matrix (ECM) molecules, including matrigel, laminin, collagens (I and IV) and intact as well as 30 and 45-kDa proteolytic fragments of fibronectin (FN) (Hauk et al., 2008; Hoke et al., 2008) . LipL32 also binds to zymogen plasminogen to generate plasmin (Vieira et al., 2010) and adheres to the proteoglycan of human cell surface receptors (Breiner et al., 2009) , cultured mammalian cells (Liu et al., 2007) and neutrophils (Wang et al., 1984) . Thus, LipL32 is an attractive target for not only leptospirosis diagnosis (Saengjaruk et al., 2002; Bomfim et al., 2005; Toyokawa et al., 2011) but also broadspectrum vaccines (Branger et al., 2005; Seixas et al., 2007; Aviat et al., 2010) and passive immunotherapy (Maneewatch et al., 2008 (Maneewatch et al., , 2009 .
Two murine hybridoma clones secreting monoclonal antibodies (mAbs) specific to the Leptospira LipL32 (mAbLPF1 and mAbLPF2) were produced previously. Both mAbs neutralized Leptospira-mediated hemolysis in vitro and rescued experimentally infected hamsters with heterologous Leptospira (Maneewatch et al., 2008 (Maneewatch et al., , 2009 ). Moreover, single-chain variable fragments (mouse ScFv) and humanized-ScFv of mAbLPF1 retained the therapeutic effects of the intact mAb in hamsters infected with heterologous Leptospira spp. (Maneewatch et al., 2009) . This study was conducted to determine peptide epitopes of mAbLPF1 and mAbLPF2 and their characteristics, to provide insight into the molecular mechanisms of Leptospira neutralizing antibodies.
Materials and methods

Leptospira cultures and antigens
Leptospira spp. were cultured at 308C under aerobic conditions in liquid Ellinghausen-McCullough -Johnson -Harris (EMJH) medium (10% albumin-polysorbate-80 Leptospira enrichment) (Difco, MI, USA). Whole-cell lysates of individual cultures were prepared (Saengjaruk et al., 2002) and the protein content of each preparation was determined using Bradford reagents.
Recombinant full-length LipL32 protein (LipL32-FL), consisting of 272 amino acids, was produced from a transformed BL21(DE3) Escherichia coli clone carrying lipl32-FLpET23a(þ) plasmid (Maneewatch et al., 2008) . The bacterial colonies were inoculated into the Luria-Bertani (LB) broth containing 100 mg/ml ampicillin and cultured at 378C with shaking at 200 rpm until the OD 600 nm was 0.2. Expression of the recombinant protein was induced by adding 0.2 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) to the culture and bacteria were grown for 3 h. The recombinant protein in the E. coli lysate was purified using Co 2þ metal-resin and gradients of imidazole solutions. The purified recombinant LipL32-FL was able to bind to ECM, plasma FN and heparin sulfate (HS), which were the inherent property of the native LipL32 (Hauk et al., 2008) . The recombinant protein was also tested for binding to cell membrane lipid components, i.e. cholesterol (C), phosphatidylcholine (PC), as well as mammalian (Madin-Darby canine kidney, MDCK) cell surface.
Two N-terminally truncated LipL32 recombinant proteins (LipL32-1 and LipL32-2) were prepared; these contained amino acid residues 91-272 and 171-272, respectively. Two DNA sequence nucleotides (nts), 271-816 lipl32-1 and 511-816 lipl32-2, were constructed by an inverse polymerase chain reaction (IPCR) (Ochman et al., 1988 ) using lipl32-FLpET23a(þ) plasmid as a template. The sequences of oligonucleotide primers used in the IPCR are shown in Supplementary Table SI. Figure 1 illustrates the map of pET23a(þ) carrying the lipl32-FL-insert and the direction of IPCR amplification. DNA sequences encoding truncated lipl32 segments were individually amplified by PCR from lipl32-FL-pET23a(þ) plasmid DNA template, using the reverse primer sequence p23/R and the respective forward primers. The forward and reverse primers amplified the DNA template in opposite directions to the conventional PCR. The 5 0 -end of the reverse primer sequence p23/R specific to NdeI restriction site of the pET23a(þ) backbone amplified the template toward the T7 promoter, while the forward primer for amplification of DNA sequence coding for the truncated LipL32-1 (L271/F) started at nucleotide (nt) 271 of the lipl32-FL-insert toward the 3 0 -end of this DNA construct. The forward primer of the truncated LipL32-2 (L511/F) started the amplification at nt511 of the lipl32-FL-insert toward the 3 0 -end. The NdeI endonuclease sites were included in the primer sequences at the 5 0 -end of the forward and 3 0 -end of the reverse primers to facilitate subsequent gene cloning. PCR amplicons were purified, digested with NdeI endonuclease and subsequently ligated using T4 DNA ligase (NEB, MA, USA). The resulting plasmids, lipl32-1-pET23a(þ) and lipl32-2-pET23a(þ), were introduced separately into competent BL21(DE3) E. coli by a heat-shock method. The presence of individual recombinant plasmids in the transformed E. coli was verified by DNA sequencing. Recombinant LipL-32-1 and LipL32-2 were purified from the appropriate transformed E. coli lysates as for the LipL32-FL. All of the three recombinant LipL32 proteins were subjected to 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS -PAGE), transferred onto nitrocellulose membranes (NC), blocked with blocking buffer (3% bovine serum albumin, BSA, in PBST), incubated with mouse monoclonal anti-6Â-His antibody (1 : 3,000) and subsequently incubated with goat anti-mouse IgG immunoglobulin-alkaline phosphatase (AP) conjugate (diluted 1 : 3,000) (Southern Biotechnology, AL, USA). Antigenantibody reactive bands were revealed using a BCIP/NBT chromogenic substrate (KPL, MA, USA).
Bioactivities of the recombinant LipL32-FL protein
Interaction of the recombinant LipL32-FL protein with various host components was studied by using an indirect enzyme-linked immunosorbent assay (ELISA) (Barbosa et al., 2006; Tung et al., 2010) , included plasma FN (affinity purified from human plasma by melting the gelatin immobilized on membrane as described previously by Chifflet et al., 2004) , matrigel ECM basement membrane (containing majority of laminin, collagen I and entacin isolated from Engelbreth-Holm-Swarm mouse sarcoma) and HS (Becton Dickinson, Canada), which was the reported inherent property of the native Lip32 protein. Major lipid components of mammalian (MDCK) cell membrane, i.e. C and PC (egg yolk L-a-PC from Sigma, MO, USA) were also included in the LipL32-FL binding assays. Recombinant HlpA sugar transferase produced from L. interrogans serovar Copenhageni and non-acetylated fraction V bovine serum albumin (Thermo Fisher Scientific, USA) served as irrelevant Leptospira protein and background binding controls, respectively. Triplicate wells of ELISA plate (Nunc-Immuno Plate MaxiSorp Surface) were coated separately with the test materials: 100 ml of phosphate buffered saline (PBS) containing 1 mg of matrigel ECM/FN/BSA, 100 ml of PBS containing 1.2 mg of HS and the plate was kept at 48C overnight, and 100 ml of absolute ethanol containing 10 mg of C/PC and kept at 378C until dried. After the unbound materials were washed away with 0.05% Tween-20 in PBS (PBST) and the unoccupied sites on the plastic surface blocked with 1% BSA in PBS, 150 ml of recombinant LipL32-FL protein or 1 mg of HlpA sugar transferase in PBS was added individually and to appropriate wells. The plate was then kept at 378C for 1 h. The recombinant Fig. 1 . Genetic map of pET23a(þ) carrying the lipl32-FL insert and directions of IPCR amplifications. The lipl32 coding sequence (Nucleotides 1-816) was inserted into the pET23a(þ) plasmid via HindIII and XhoI restriction sites in the cloning region. The transcription start site of the recombinant plasmid was from NdeI, followed by coding sequences for T7 tag, lipl32-FL and C-terminal his tag. In IPCR, the 5 0 -end of p23/R reverse primer annealed to NdeI at nucleotide 260 and amplified the template toward the T7 promoter (lower arrow). The forward primers, L271/F and L511/F, bound to nucleotides 271 and 511 of the lipl32, respectively, and amplified the template toward the his tag (upper arrows).
LipL32-FL/HlpA protein bound to the immobilized test materials/controls, and was detected by adding 100 ml of mouse monoclonal anti-6Â-His antibody (1 : 3000 in PBS) and incubated at 378C for 1 h. Goat anti-mouse/rabbit IgG-horseradish peroxidase (HRP) conjugate (Southern Biotechnology, USA) and ABTS (KPL, MD, USA) substrate were used for the color reaction. After terminating the enzymatic reaction by adding 50 ml of 1% SDS to each well, the OD 405 nm of content in each well was measured against a reagent blank using a Multiscan EX microplate reader (Labsystems, Helsinki, Finland) . Three independent experiments were performed.
LipL32-FL was also tested for their binding to the surface of mammalian cells using HlpA as the irrelevant Leptospira protein control. MDCK cells in Dulbecco's modified Eagle medium (DMEM; Invitrogen, USA) containing supplements and antibiotics were seeded into individual wells of a 96-well tissue culture plate (Costar) (1 Â 10 5 cells/well), which was then kept in a humidified 5% CO 2 atmosphere until the cell monolayer was obtained. LipL32-FL and HlpA proteins were added separately into the MDCK cell monolayer in triplicate. Negative control wells with PBS instead of LipL32-FL/HlpA protein were included. After incubation, all wells were washed thoroughly and subjected to the indirect ELISA procedure described above. Significant binding of the LipL32-FL to the mammalian cell surface above the binding of the HlpA protein and the PBS controls was noted. The mean + SD of OD 405 nm of the contents of the nine LipL32-FL test wells was compared with that of the HlpA and the BSA control wells. P , 0.05 was considered significantly different (Student's two-tailed t test).
Mouse mAbs
Mouse mAbs used in this study included mAbs specific to LipL32 lipoprotein of pathogenic Leptospira spp.; mAbLPF1 and mAbLPF2 (Maneewatch et al., 2008) and control mAb204D3 specific to Antigen 9 in LPS of Group D Salmonella Typhi (Chaicumpa et al., 1988) . The hybridomas were cultured either in RPMI-1640 medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum (HyClone, UK), 2 mM L-glutaMAX, penicillin and streptomycin (100 U/ml and 100 mg/ml, respectively) (Invitrogen) or in protein-free CD hybridoma medium supplemented with 2 mM L-glutaMAX (Invitrogen) at 378C in humidified 5% CO 2 . The monoclonal immunoglobulin in the hybridoma spent CD medium was concentrated and buffer exchanged to PBS, pH 7.4, using Amicon Ultra-tubes (Millipore, Billerica, MA, USA). The IgG content of each preparation was determined at OD 280 nm .
LipL32 subdomains bound by the mAbLPF1 and mAbLPF2
The LipL32-FL, LipL32-1 and LipL32-2 proteins were subjected to 15% SDS-PAGE and the separated components were blotted onto NC. Unoccupied sites on the NC were blocked with 3% BSA in PBS. After washing, all membranes were placed in individual mAb solutions (spent RPMI-1640 culture medium) and kept at 258C for 1 h. After washing thoroughly with PBST, the membranes were placed in a solution of goat anti-mouse immunoglobulin-AP conjugate (diluted 1 : 3,000). Immunoreactive bands were revealed using a BCIP/NBT substrate.
Leptospiral surface ELISA
Double antibody sandwich ELISA (Matsunaga et al., 2006) was used for determining the reactivity of mAbs to native LipL32 on intact leptospires. Whole cells of L. interrogans serovar Icterohaemorrhagiae were harvested, washed twice with EMJH base medium and immobilized with 75 mM sodium azide. A Leptospira suspension containing 10 5 cells in 100 ml was added to each well of a Maxisorb ELISA plate (Nunc, Germany) which had been coated with a rabbit anti-Leptospira polyclonal antibody (diluted 1 : 5,000) and incubated at 378C for 2 h. After washing and blocking the well surface with 3% BSA in PBST, 100 ml of mAbLPF1, mAbLPF2 and irrelevant mAb204D3 was added individually to the wells and incubated at 378C for 1 h, followed by washing three times with the PBST. Each well was then filled with 100 ml of goat anti-mouse IgG-HRP conjugate (diluted 1 : 3,000) (Southern Biotechnology) at 378C for 1 h. ABTS substrate (KPL) was added (50 ml/well). Enzyme-substrate reaction was allowed to occur at 258C in the dark for 15 min; the reaction was stopped by adding 50 ml of 1% SDS. The OD 405 nm of the content of each well was determined against the blank.
Phage mimotopes and LipL32 epitopes bound by the mAbs
TM phage display library (NEB, MA, USA) containing 2.7 Â 10 9 random 12-mer peptide sequences ( 1.5 Â 10 13 pfu/ml) was used for searching phage display peptides that bound to mAbLPF1 and mAbLPF2 ( phage mimotopes). Briefly, mAb IgG of individual hybridomas from serum-free CD medium (10 mg in 100 ml of 1Â TBS) was coated onto ELISA wells (Costar) and kept at 48C overnight. Unoccupied sites were blocked with 3% BSA in PBST at 258C for 1 h. After washing with TBS containing 5% Tween-20 (TBST), the 12-mer peptide phage display library (100 ml containing 4 Â 10 9 pfu) was added to each well and kept at 258C for 1 h. After washing away the unbound phages, the mAb-bound phages were eluted out with 0.2 M glycine -HCl, pH 2.2, and immediately neutralized with few drops of Tris, pH 9.0. The eluted phages were amplified in log-phase grown ER2738 E. coli. Phage particles in individual E. coli culture supernatants were concentrated by PEG/NaCl precipitation and used in the next panning round. Three consecutive rounds of panning were performed. Phages recovered from the final panning round were used to transfect ER2738 E. coli in top agarose overlaid on the LB/X-Gal/IPTG agar plate. After overnight incubation at 378C, 15 isolated blue plaques were picked randomly from each plate and propagated in the ER2738 E. coli. The culture supernatants containing phage particles were added with the PEG/NaCl solution. Single-stranded DNA were extracted from the precipitated phages, and the respective DNA insert in each phage clone was sequenced with the 296 gIII sequencing primer as described in the instruction manual and deduced into peptide sequences using translate tool (http://web.expasy.org/translate/).
The phage displayed peptide sequences (phage mimotopes) were multiply aligned using the MIMOX program (Huang et al., 2006) with manual adjustment to identify the mimotope consensus sequences. The consensus mimotopes were then aligned with the LipL32 amino acid sequence to locate the presumptive peptide sequences of LipL32 bound by the mAbs (LipL32 epitopes), using multiple alignments ClustalW2.1 Server.
Phage clones displaying the mimotopes that bound to mAbLPF1 and mAbLPF2 were validated by testing the binding inhibition capacity of the respective mAbs to immobilizedLipL32. Phages were propagated in ER2738 E. coli and the titers of the amplified phages were determined according to the manufacturer's instruction (New England Biolabs, USA). Phage mimotope preparations (10 10 pfu) were mixed individually with fixed amounts of each mAb and incubated at 378C for 1 h. The mAb mixed with irrelevant phages served as the control. The mixtures were added individually to the wells coated with fixed amounts of recombinant LipL32-FL. After washing, goat anti-mouse immunoglobulin-HRP conjugate and ABTS substrate were added respectively, and the OD 405 nm content of each well was determined. Percent ELISA inhibition was calculated using the formula: % ELISA inhibition ¼ [(OD 405 nm of the control, in which the mAb and irrelevant phage mixture was added to the well 2 the OD 405 nm of the test or wells added with phage mimotope and mAb mixture)/ (OD 405 nm of control)] Â 100.
Prevalence of LipL32 epitopes among Leptospira spp. and LipL32 protein superfamily Peptide epitopes of mAbLPF1 and mAbLPF2 were multiply aligned through ClustalW2.1 Server with LipL32 peptide sequences of several genomospecies of pathogenic and intermediate Leptospira spp. in the NCBI database, using BLASTP 2.2.26þ Server (http://www.ncbi.nlm.nih.gov/Entrez/) (Altschul et al., 1997) . Prevalence of the epitopes was determined. Moreover, the epitope peptides were also aligned with the orthologous proteins of the LipL32 superfamily, retrieved from the annotated conserved domain database (http://www.ncbi.nlm.nih. gov/Entrez/) (Marchler-Bauer et al., 2009).
Structural characterization of LipL32 epitopes
Three-dimensional (3D) structures of LipL32 fragments containing epitopes bound by mAbLPF1 and mAbLPF2 were constructed by using a homology model, available from the PDB (ID 2WFK) database via SWISS-MODEL Server (Amold et al., 2006) . The reliability of the constructed models was verified by QMEAN Z-score calculation (Benkert et al., 2011) and visualizating using the POLYVIEW visualization server (Porollo and Meller, 2007) . Alpha-helix conformation of the protein was analyzed by HELIQUEST server (Gautier et al., 2008) . Lysine acetylation (K-Ac) sites were predicted from the LipL32 sequence by PAIL server.
Binding inhibition of recombinant and native LipL32 to host components and mammalian cells by mAbs
Both mAbLPF1 and mAbLPF2 were tested for their ability to inhibit binding of the recombinant and native LipL32 in wholecell lysate to C, PC and MDCK cell monolayer. MAb204D3 was used as irrelevant control. Two micrograms of the recombinant LipL32 and the L. interrogans Copenhageni lysate were separately incubated with individual mAbs (2 mM) and kept at 258C for 2 h prior to adding the mixtures into the immobilized FN, ECM, HS, C, PC or the MDCK cell monolayer in ELISA wells and kept at 258C for 1 h. After washing, mouse anti-6Â-His and rabbit anti-Leptospira polyclonal antibodies were used for detecting LipL32 in the wells. ELISA color reactions were performed. The OD 405 nm of the content of each well was determined against the reagent blank. 
Results
Recombinant LipL32 proteins
Recombinant LipL32-FL (Residues 1-272), LipL32-1 (Residues 91-272) and LipL32-2 (Residues 171-272) were successfully expressed as fusion proteins with an N-terminal T7 peptide tag and C-terminal 6Â-histidine tag in transformed BL21(DE3) E. coli under IPTG induction. All proteins were found in both soluble and insoluble E. coli fractions (data not shown). Western blot patterns of the three recombinant proteins with the relative molecular sizes of 29.6, 20.0 and 13.7 kDa, respectively, are shown in Lanes 1-3 of Supplementary Fig. S1 . The recombinant LipL32-FL was found to have native LipL32 bioactivities in binding to tested host components, including FN, matrigel ECM and HS. The protein also bound to C, PC and MDCK cells and gave the OD 405 nm above the HlpA protein and BSA controls (P , 0.05) (Supplementary Fig. S2 ).
Recombinant LipL32 subdomains bound by mAbLPF1 and mAbLPF2
SDS-PAGE and Coomassie Brilliant Blue G250 stained patterns of LipL32-FL, LipL32-1 and LipL32-2 are shown in Fig. 2A . Western blot analysis revealed that mAbLPF1 bound to full-length LipL32 as well as to the two truncated LipL32 proteins (Fig. 2B) , while mAbLPF2 recognized LipL32-FL and LipL32-1 (Fig. 2C) only. The results of mAb reactivity assessed by Western blotting were conformed to the ELISA results (data not shown).
Binding of mAbs to Leptospira spp.
The leptospiral surface ELISA results showed that both mAbLPF1 and mAbLPF2 bound to intact Leptospira bacteria (ELISA signals at OD 405 nm above the irrelevant control were 0.427 + 0.59 and 0.447 + 0.32, respectively; and ELISA signal of the binding by the irrelevant mAb204D3 was 0.06 + 0.15). There was no significant difference in Leptospira binding between the two mAbs.
Phage peptides (mimotopes) that bound to mAbs
From the 15 randomly picked phage clones that appeared on the selective agar plate spread with mAbLPF1 bound phages, three mimotope types (KPHSIPLLDLTR, KPPQMPLYNLSA and NVYPTPESSLSL) were found in two phage clones each (Table I) , while the other mimotope types were found in each one of the phages (data not shown). The consensus peptide of the four mimotopes was -----PLLNLS-. Three predominant mimotope types were obtained from the 15 phage clones derived from panning with immobilized mAbLPF2: NPPPAHSPANFT (three clones), NPPPAHSPANFH (two clones) and NYLPLLESSLQY (three clones), of which the consensus sequence was NPPPAHSPANF2 (Table I ). The consensus peptide mimotopes were aligned with the peptide sequence of LipL32 protein (accession no. YP_001316.1). It was found that the presumptive epitope of LipL32 matched the consensus mimotope of mAbLPF1 and was located at residues P243, L244, I245, H246, L252 and Q253, while the consensus mimotope of mAbLPF2 matched with linear residues 122PEEKSMPHW130 of the LipL32 protein (Table I) .
The results of competitive ELISA for determining the ability of the respective phage mimotopes to inhibit the binding of mAbLPF1 and mAbLPF2 to LipL32 are shown in the last column of Table I . The results of ELISA inhibition indicated that the phage mimotopes carried many amino acid residues analogous to LipL32 which validated the mimotope search results.
Prevalence of the LipL32 epitopes
The epitope peptide sequences of the mAbLPF1 (PLIH-----LQ) and mAbLPF2 (PEEKSMPHW) were multiply aligned with 70 LipL32 peptide sequences of Leptospira spp. belonging to 11 genomospecies: L. interrogans (serovars Australis, Autumnalis, Balico, Canicola, Copenhageni, Grippotyphosa, Hardjo, Hebdomadis, Icterohaemorrhagiae, Jalna, Javanica, Kremastos, Lai, Manilae, Mini, Paidjan, Pomona, Pyrogenes and Wolffi), L. noguchii (serovar Pomona), L. kirschneri (serovar Bim), L. borgpetersenii (serovars Ballum, Hardjo-bovis, Javanica, Mini and Tarassovi), L. weilii (serovar Manhao II), L. santarosai (serovar Shermani), L. alexanderi 
. SDS-PAGE analysis of purified recombinant LipL32 proteins (A), and Western blot results of LipL32 proteins probed with mAbLPF1 (B) and mAbLPF2 (C). (A) SDS-PAGE patterns of purified recombinant
LipL32-FL (residues 1 -272), LipL32-1 (residues 91-272) and LipL32-2 (residues 171-272) proteins (Lanes 1-3, respectively). The same proteins as in (A) were probed with mAbLPF1 (B) and mAbLPF2 (C) and the antibody reactivity was detected by BCIP/NBT substrate. The mAbLPF1 reacted to full-length and both truncated recombinant proteins, indicating that the epitope of mAbLPF1 is located within residues 171 -272. The mAbLPF2 reacted only to LipL32-FL and LipL32-1, indicating that the mAbLPF2 epitope is located within residues 91-170 of the LipL32 molecule. Irrelevant mAb204D3 was used as antibody control and did not show reactivity to the LipL32 proteins (data not shown). (Tables II and III) . There are four variants of the mAbLPF1 epitope (Variants 1 -4) among the 70 LipL32 NCBI database sequences (Table II) . Variant 1 (PLIH-----LQ) was predominant (62 of 70) among the pathogenic Leptospira spp., Variant 2 (PAVH-----LQ) was found in one strain of pathogenic L. interrogans, Variant 3 (PIVH-----LQ) was found in two species of intermediately pathogenic Leptospira spp. (L. inadai and L. inada) and Variant 4 (PILH-----LE) was found in two strains of the intermediately pathogenic L. licerasiae. There were six variants of the mAbLPF2 epitope (Variants 1 -6) ( Table III) . Variant 1 (122PEEKSMPHW130) was predominant (59 of 70) among the pathogenic species. Variant 2 (P122R) and Variant 3 (P122L) were found in two strains and one strain, respectively, of the pathogenic Leptospira spp. Variant 4 (H129S) was found in L. kmetyi. Variant 5 (H129N) was found in both pathogenic and intermediately pathogenic species. However, Variants 2 -5 had one conserved polar amino acid substitution. Variant 6 had S126C and two amino acid deletions at positions 127 -128 and was found in one LipL32 sequence of L. interrogans.
Multiple alignments were also performed between the epitope sequences and orthologous proteins of the LipL32 superfamily including three outer membrane proteins (OMPs) of bacteria of the genus Pseudoalteromonas: P. tunicata-D2 (Holmstrom et al., 1998) , P. rubra (ATCC29570) and P. spongiae (UST010723-006); two proteins of the genus Cellulophaga: C. lytica (DSM7489) and C. algicola (DSM14237) (Bowman, 2000) ; LipL32 proteins from Moritella sp. (PE36), Marinomonas mediterranea (MMB-1), unidentified Eubacterium (SCB49); and the OMP of Treponema brennaborense (DSM12168). The LipL32 epitope sequences were not found in any of the orthologous proteins of the LipL32 superfamily derived from other microorganisms (Fig. 3) .
Locations and structures of the peptide epitopes
The mAbLPF1-specific epitope, i.e. P243, L244, I245, H246, L252 and Q253, was located at the previously reported b13 region and C-terminal a-helix (a6) of the LipL32 crystal structures (Vivian et al., 2009) (Fig. 4A) . The a6 helix contained potential internal lysine acetylation (K-Ac) sites, i.e. K254, K264 and K265. Analysis of this helix using HELIQUEST server revealed that the helix had surfaceexposed hydrophilic residues (Q253, Q255, I257, S262) and electropositive (K254, K264 and K265) and negative patch (E250, E251, E260, E261) on one side and hydrophobic residues (P249, L252, A256, A259, A266) on another side (Fig. 4B) . The amphipathic helix is important in membrane binding and insertion (Thiyagarajan et al., 2004) . 
L. licerasiae I *::* *:
a From 70 LipL32 sequences of the database (accessed on August 2012). There were three LipL32 database sequences that had C terminal deletions (D243-272, D248-272 and D252-272). The linear epitope of mAbLPF2 (122PEEKSMPHW130) was located at the surface-exposed a1 and a2 of b7-b8 (green shade in Fig. 4C ).
MAbs mediated the inhibition of binding of recombinant and native LipL32 proteins to host components
The irrelevant mAb204D3 did not inhibit the binding of recombinant LipL32 or the Leptospira lysate to the test materials (data not shown). Fig. 5A shows the percentage mAb-mediated inhibition of the recombinant LipL32-FL binding to C, PC and MDCK cells. Binding of the LipL32-FL to C, PC and MDCK cells was inhibited by mAbLPF1 at rates of 72, 54 and 24%, respectively. The binding inhibition mediated by mAbLPF2 was at rates of 56, 39 and 30%, respectively. The two mAbs did not show significant binding inhibition of rLipL32-FL to FN, ECM and HS ligands when compared with inhibition by the irrelevant mAb204D3 control. Fig. 3 . Peptide epitopes of the mAbLPF1 and mAbLPF2 among orthologous proteins of the LipL32 superfamily. Peptide epitopes of the mAbLPF1 and mAbLPF2 were multiply aligned through ClustalW2.1 Server with LipL32 linear sequences of orthologous proteins of the LipL32 superfamily of the database using BLASTP 2.2.26þ Server. Black shade, identical amino acid; gray shade, conserved/semi-conserved amino acid; dash, deleted amino acid. LI, L. interrogans Lai; PT, P. tunicata D2; MM, Marinomonas mediterranea MMB-1; PR, P. rubra ATCC29570; PS, P. spongiae UST010723-006; MO, Moritella sp. PE36; CA, C. algicola DSM14237; CL, C. lytica DSM7489; EU; Eubacterium sp. SCB49; T, T. brennaborense DSM12168. The epitopic peptides of the mAbLPF1 and mAbLPF2 were absent from the orthologous proteins of the LipL32 superfamily derived from other bacteria indicating that the epitopes are conserved for only the Leptospira spp. A helical wheel projection of 18 amino acids (249PEELQKQAIAAEESLKKAA267) of C-terminal a6 of LipL32 where the mAbLPF1 epitope is located plotted with 1008 consecutive angle of rotation and analyzed by HELIQUEST server and http://cti.itc.virginia.edu. The helix revealed a cluster of hydrophobic patches (PLAALA) on one side and the surface-exposed hydrophilic and charged residues on another side (Vivian et al., 2009 ). (C) Cartoon representation of the 3D structure of b6-b8 (residues 92-139 of LipL32), where the surface-exposed peptide epitope of mAbLPF2 (light green) is located.
Therapeutic epitopes of Leptospira LipL32 protein
The two mAbs could also inhibit the binding of the Leptospira lysate containing native LipL32 to the C, PC and MDCK cells, as shown in Fig. 5B ; the percentage inhibition by mAbLPF1 was 98, 80 and 44%, respectively, and by mAbLPF2, 75, 52 and 54%, respectively.
Discussion
Penicillin is the primary drug of choice for the treatment of leptospirosis. Occasionally, Jarisch-Herxheimer reaction occurs in antibiotic-treated cases due to the massive amounts of toxic material released from the lysed bacteria (Watt and Warrell, 1995; Pound and May, 2005) . In a previous study, two mouse mAbs specific to LipL32 of pathogenic Leptospira spp., their respective single-chain antibody fragments (ScFv) and their humanized-ScFv were produced. When passively given to hamsters experimentally infected with heterologous Leptospira spp., the antibodies were able to rescue the animals from lethal leptospirosis. They also inhibited pathogenic Leptospiramediated human erythrocyte lysis in vitro (Maneewatch et al., 2008 (Maneewatch et al., , 2009 ). Thus, the antibodies, particularly the humanizedScFv, have a high potential for further development as a safe adjunctive, if not sole, remedy for use in the treatment of leptospirosis, especially in antibiotic-allergic subjects. In this study, locations, structural characteristics and biofunctions of peptide epitopes of both mAbs were studied in order to elucidate the molecular mechanisms of the mAb in mediating Leptospira's neutralizing effects.
Recombinant full-length LipL32 (LipL32-FL, 272 amino acids) were produced and purified. LipL32-FL was found to have an inherent molecular matrix adhesive property of the Leptospira native counterpart, i.e. it bound readily to the previously reported host components, including plasma FN, matrigel ECM and HS (Hauk et al., 2008; Hoke et al., 2008) . This study also noted the binding of the recombinant protein to C and PC, which are the predominant membrane lipid components of mammalian cells, and to intact MDCK cells. The most important prerequisite step in the pathogenesis of many microorganisms is their ability to bind to the host component/ cell/tissue, and Leptospira spp. is not an exception (Patti et al., 1994; Cinco, 2010) .
To analyze the peptides of the LipL32 neutralizing epitopes bound by the mAbs, a search of conventional protein -protein interaction by Western blotting and phage mimotope from the random 12-mer peptide phage display library was conducted (Perera et al., 2008; Thanongsaksrikul et al., 2010; Pissawong et al., 2013; Yodsheewan et al., 2013) . Two recombinant N-terminally D90-and D170-LipL32 proteins were produced for determining the LipL32 portions bound by mAbLPF1 and mAbLPF2. The results of western blot analysis suggested that the mAbLPF1 bound to the epitope located between amino acids 171-272, which has been shown to be immunogenic and important for LipL32 binding to host components (Hauk et al., 2008; Hoke et al., 2008) . Although mAbLPF2 did not bind to the recombinant D170 LipL32 protein, it bound to the recombinant D90 protein. Crystallographic analysis had identified that the b6-b8 region of LipL32 protein (residues 92-139), where epitope of the mAbLPF2 is located (a1 and a2), might have the protein -protein/protein -ligand interaction functions (Hauk et al., 2009; Vivian et al., 2009) .
Mapping epitope peptides, by searching for phage mimotope peptide consensus sequence and multiple alignments of the sequence with the linear amino acid sequence of LipL32 of the database, not only confirmed the locations of the mAb epitopes guided by the Western blot results, but also revealed the amino acid residues and features of the epitopes. The epitope sequence of mAbLPF1 (PLIH-----LQ) was conformational, consisting of many hydrophobic residues (243PLIN/ H246) in the b13-turn (Table I) or P249, L256A and I263L of the a6 hydrophobic patch (Fig. 4A) (Hauk et al., 2009; Vivian et al., 2009) . Previous study has shown that the amphipathic a helix is involved in membrane binding and membrane insertion (Thiyagarajan et al., 2004) . LipL32 protein has been found to have hemolytic activity (Lee et al., 2000; Hauk et al., 2005) . Thus, this epitope may have a functional role in the hydrophobic interaction and/or hemolytic activity of LipL32. It has also been shown that mAbLPF1 inhibited Leptospiramediated hemolysis and rescued Leptospira-infected hamsters from death (Maneewatch et al., 2008) . It is therefore plausible to conclude that mAbLPF1 exerted the neutralizing/therapeutic activity by interfering with the pathogenic activities of the LipL32 epitope. The mimotope consensus sequence of the Inhibition of the binding of the recombinant (A) and the native LipL32 (B) to host components including immobilized C, PC (10 mg in 100 ml) and MDCK cells by 2 mM mAbLPF1 and mAbLPF2. The bound proteins were detected as described in Materials and methods. The OD 405 nm was determined against the reagent blank. Each bar represents the mean of percent binding inhibition mediated by individual mAbs from three independent experiments. *P , 0.05 mAbLPF2 matched with linear 122PEEKSMPHW130 residues of the LipL32 a1 and a2 between b7 and b8. This portion is surface exposed and easily accessible by the interacting partner(s) as well as specific antibodies. By inhibiting protein interaction with the host component(s), mAbLPF2 may exert a neutralizing effect of Leptospira infectivity and pathogenicity.
There were four mAbLPF1 epitope variants among the pathogenic and intermediately pathogenic clades of Leptospira spp. (Table II) . Most of the LipL32 sequences (62 of 70) of the database carried the Variant-1 epitope. Few strains, however, had amino acids L244A and I245V of the Variant 2, and L244I and I245V of the Variant 3. Nevertheless, these amino acid substitutions are conserved non-polar residues, which retain the hydrophobic activity of the amino acids 244LIH246 of Variant-1. The overall findings indicate that the mAbLPF1 epitope is highly conserved among the pathogenic and intermediately pathogenic species of Leptospira spp. There were six mAbLPF2 epitope variants due to one amino acid substitution (P122R, P122L, S126C, H129N and H129S of Variants 2 -6, respectively). However, these substituted amino acids of Variants 4 -5 should retain the hydrophilic properties of mAbLPF2 epitope Variant 1 located at the hydrophilic pocket, which has been shown to be the polypeptide binding groove of the LipL32 protein (Hauk et al., 2009 ).
In conclusion, epitopes of mAbLPF1 and mAbLPF2 are highly conserved among the pathogenic and intermediately pathogenic Leptospira spp., and are absent from proteins of the LipL32 superfamily of other microorganisms. The locations, tertiary structures and amino acid compositions indicated that both epitopes are involved in the interaction of LipL32 protein with the host factors/cells, which is a prerequisite step in Leptospira infectivity and pathogenicity. This study not only enlightens the molecular mechanisms of the neutralizing mAbLPF1 and mAbLPF2, i.e. prevents LipL32 binding to host constituents, but also elaborates the potential of the two LipL32 regions as diagnostic and vaccine targets for leptospirosis.
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